Published online Jan 28, 2014. doi: 10.3748/wjg.v20.i4.1107
Revised: October 26, 2013
Accepted: November 12, 2013
Published online: January 28, 2014
Processing time: 123 Days and 13.2 Hours
AIM: To conduct a meta-analysis to evaluate the prognostic role of hypoxia inducible factor-1α (HIF-1α) expression in gastric cancer.
METHODS: The PubMed, EMBASE, and Web of Science databases were searched systematically for all articles published in English before August, 2013. Pooled effect was calculated from the available data to evaluate the association between HIF-1α expression and 5-year overall survival and tumor clinicopathological features in gastric cancer patients. Pooled odds ratios (ORs) with 95%CIs were calculated using either a fixed-effects or a random-effects model.
RESULTS: Nine studies matched the selection criteria, which reported on 1103 subjects, 548 of whom had HIF-1α positive expression (50%). This meta-analysis indicated that HIF-1α positive expression in gastric cancer correlated with lower 5-year overall survival (OR = 0.36; 95%CI: 0.21-0.64), worse tumor differentiation (OR = 0.38; 95%CI: 0.23-0.64), deeper invasion (OR = 0.42; 95%CI: 0.32-0.57), higher rates of lymph node metastasis (OR = 2.23; 95%CI: 1.46-3.40), lymphatic invasion (OR = 2.50; 95%CI: 1.46-4.28), and vascular invasion (OR = 1.80; 95%CI: 1.29-2.51), and higher TNM stage (III + IV) (OR = 0.31; 95%CI: 0.15-0.60).
CONCLUSION: HIF-1α positive expression indicates a poor prognosis for patients with gastric cancer. Further studies are required to confirm these results.
Core tip: We conducted a meta-analysis to evaluate the correlation between hypoxia inducible factor-1α (HIF-1α) expression and clinical outcome in gastric cancer patients, and reported that HIF-1 positive expression indicates a poor prognosis for patients with gastric cancer. This is the first comprehensive and detailed meta-analysis to assess the association of HIF-1α positive expression with 5-year overall survival and tumor clinicopathological features for gastric cancer patients. We believed that the results will provide useful information for clinical decision-making regarding gastric cancer.